Skip to main content
main-content

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Editors' pick

12-14-2018 | Risk factors | Feature | Article

Sleep duration: Waking up to a major metabolic risk factor

The effect of sleep duration on glucose regulation and cardiometabolic risk is becoming an increasingly high-profile issue. medwireNews takes a look at the latest evidence, which shows the gravity of the problem but also offers some solutions.

Maturity-onset diabetes of the young (MODY)

This 15-minute case presents the characterization, diagnosis and management of maturity-onset diabetes of the young (MODY) and discusses the pros and cons of predictive genetic testing for MODY.

01-14-2019 | Mental health | medwireNews | News

High mental illness burden in young-onset type 2 diabetes

Over a third of time spent in hospital before the age of 40 years by patients who develop type 2 diabetes by this age is due to mental illness, report researchers.

Latest from across the site

01-17-2019 | Glucokinase activators | News

Hepatic glucokinase activation may improve glycemic control in type 2 diabetes

The hepatoselective glucokinase activator TTP399 reduces glycated hemoglobin levels without increasing the risk for hypoglycemia among patients with type 2 diabetes, suggest findings from the phase IIb AGATA trial.

Source:

Sci Transl Med 2019; doi:10.1126/scitranslmed.aau3441

01-16-2019 | Diabetes prevention | News

Observational data highlight importance of diabetes prevention in midlife

Individuals who maintain a blood glucose level below the diabetes threshold during middle age have a lower risk for cardiovascular disease than those who convert to diabetes during this time, observational study data show.

Source:

Diabetes Care 2019; doi:10.2337/dc18-1773

01-16-2019 | Obesity | News

Gastric bypass pros and cons reported for type 2 diabetes patients

Overweight and obese patients with type 2 diabetes who undergo gastric bypass have significantly lower risks for death, cardiovascular disease, and severe kidney disease than those who do not have such surgery, Swedish research shows.

Source:

BMJ Open 2019; doi:10.1136/bmjopen-2018-023882

01-14-2019 | Mental health | medwireNews | News

High mental illness burden in young-onset type 2 diabetes

Over a third of time spent in hospital before the age of 40 years by patients who develop type 2 diabetes by this age is due to mental illness, report researchers.

Source:

Ann Intern Med 2019; doi:10.7326/M18-1900

01-09-2019 | Nephropathy | News

Albuminuria backed as kidney disease treatment response marker

The results of two individual patient data meta-analyses support albuminuria as a surrogate marker of treatment response in patients with chronic kidney disease, particularly those with high baseline albuminuria.

Source:

Lancet Diabetes Endocrinol 2019; doi:10.1016/S2213-8587(18)30314-0
Lancet Diabetes Endocrinol 2019; doi:10.1016/S2213-8587(18)30313-9

01-08-2019 | Dapagliflozin | News

Observational data hint at additional dapagliflozin benefits

A real-world study based on DECLARE-TIMI 58 inclusion and outcome criteria shows that dapagliflozin not only reduces cardiovascular risk among patients with type 2 diabetes, in line with the original trial results, but may also lower all-cause mortality risk.

Source:

Diabetes Obes Metab 2019; doi:10.1111/dom.13627

medwireNews@EASD2018

The 2018 EASD Annual Meeting took place in Berlin from the 1st to 5th October. Click here for news and expert commentary, including the EASE, PREVIEW, and HARMONY trials.

Meet our Editorial Board

New Content Item Meet our Advisory Board

Latest from us on Twitter

Trending this week

image credits